Investor Relations

Cyberjaya, 29 April 2025 - DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, has announced its fourth quarter (“4QFY25”) and full-year financial results for the year ended 28 February 2025 (“FY25”) for the Company and its subsidiaries (“DXN Group” or the “Group”).

Since its listing on Bursa Securities in May 2023, DXN has delivered uninterrupted year-on-year (“YoY”) growth, continuing this momentum in FY25 with another record set of results. In FY25, revenue climbed 5.8% YoY to a new record of RM1.9 billion, exceeding the RM1.8 billion achieved in the previous year. This achievement was primarily driven by robust sales in key markets such as Peru, Bolivia, Middle East, and Turkey, supported by sustained and effective marketing efforts that actively kept members engaged throughout the year.

Sustained operational strength continued to underpin DXN’s profitability in FY25, with earnings before interest, tax, depreciation, and amortisation (“EBITDA”) rising 8.6% YoY to RM583.2 million, up from RM537.1 million in FY24. Profit before taxation (“PBT”) also recorded a strong 9.1% YoY increase to RM522.7 million, compared to RM479.0 million in the previous year. Meanwhile, profit after taxation and non-controlling interests (“net profit”) reached a new all-time high of RM329.0 million, representing a 5.8% YoY growth from RM311.0 million in FY24. Removing the impact of a foreign exchange loss of RM25.9 million recorded during FY25, net profit would have amounted to RM354.9 million, reflecting a stronger 14.1% YoY growth.

Executive Chairman and Founder of DXN, Datuk Lim Siow Jin (拿督林孝仁) shared, “We are pleased to have delivered another set of record-breaking financial results this year, reaffirming the resilience of our business model and the effectiveness of our long-term growth strategies. This strong performance reflects not only the continued momentum across our key markets but also the encouraging progress from our expansion into new frontiers such as Brazil and Argentina.”

“Our recent entry into Brazil and Argentina has gained encouraging traction, as sales and member recruitments are growing steadily. These markets represent significant opportunities within the broader Latin American region. We are well-positioned to capture this potential by leveraging our robust member network and strong brand presence in neighbouring countries such as Mexico, Peru, Bolivia, and Colombia.”

“Looking ahead, DXN remains focused on sustaining its growth trajectory through ongoing product innovation, driven by robust research and development, alongside continued enhancements in production efficiency. These strategic efforts are key to meeting evolving consumer needs and reinforcing our role as a leading player in the global health and wellness sector over the long term,” he concluded.

On a quarterly basis, sales in local currencies grew in 4QFY25 compared to 4QFY24, driven by healthy demand across key markets. However, revenue in Ringgit terms declined marginally by 2.5% year-on-year to RM458.9 million in 4QFY25, from RM470.6 million in 4QFY24, mainly due to unfavourable currency translation from a stronger Malaysian Ringgit. EBITDA rose 11.5% YoY to RM147.8 million, while net profit increased 7.2% to RM84.7 million, supported by improved production efficiency and the reversal of certain previously accrued marketing expenses.

Riding on its stronger financial performance, DXN has continued to reward shareholders with higher dividends. As part of DXN’s ongoing commitment to shareholder returns, the Board of Directors has declared a fourth interim dividend of 1.0 sen per ordinary share for FY25, amounting to RM49.7 million. The dividend will be paid on 30 May 2025.

As at 28 February 2025, total dividends declared for FY25 amounted to 3.7 sen per ordinary share, equivalent to RM184.0 million, up from 3.6 sen per ordinary share, or RM179.3 million, in FY24. The FY25 dividend represents a payout of 55.9% of net profit, underscoring its continued commitment to delivering shareholder value in line with its dividend policy of distributing at least 50% of net profit to shareholders.

DXN ended FY25 with a solid financial and liquidity position, anchored by a strong net cash position and low gearing. As at 28 February 2025, the Group’s cash and cash equivalents stood at RM672.2 million, more than four times its total loans and borrowings of RM154.9 million. This was further supported by a robust net operating cash inflow of RM445.0 million during the year. With a minimal debt profile, DXN is well-positioned to capitalise on future growth opportunities while continuing to deliver consistent value to shareholders.